Skip to content
drillr.ai
Sign up

ETON

Eton Pharmaceuticals, Inc.

NASDAQ · Healthcare · Biotechnology · US

$58.45
−2.42%
Ask drillr

  • Aug 13, 2026, 20:05 UTC

    Eton Pharmaceuticals reported its financial results for the quarter ended June 30, 2026.

    Source:

  • Aug 5, 2026, 10:50 UTC

    Eton Pharmaceuticals licensed U.S. rights to late-stage product candidate ASN-001 (timolol topical gel) from Auson Pharmaceuticals, expanding its infantile hemangioma franchise.

    Source:

  • Aug 4, 2026, 00:00 UTC

    Eton Pharmaceuticals announced the promotion of Danka Radosavljevic to Chief Operating Officer, effective July 31, 2026.

  • Jul 29, 2026, 10:50 UTC

    Eton Pharmaceuticals submitted a Prior Approval Supplement to the FDA to expand the indication of KHINDIVI oral solution to younger pediatric patients.

    Source: